Medivation: Sanofi’s Bid ‘Significantly Undervaluing’ Pipeline
May 03, 2016 at 11:53 AM EDT
Credit Suisse analyst argues that Sanofi's ( SNY ) $52.50 a share big for Medivation ( MDVN ) is "significantly undervaluing" its pipeline:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.